Ef?cient internalization of peptide-conjugated SPIONs in dendritic cells for tumor targeting

Journal of Nanoscience and Nanotechnology

Volumn 12, Issue 7, 2012, Pages 5191-5198

  Kim, Do Kyung ^a   Chang, Ji Hong ^b   Kang, Yoon Joong ^b  

^a Konyang University   (South Korea)

^b Jungwon University   (South Korea)

Author keywords

Dendritic Cells; Iron Oxide; Nanoparticles; Peptide; Superparamagnetic

Indexed keywords

ANTIGEN DELIVERY; ANTIGENIC PEPTIDES; CANCER IMMUNOTHERAPY; DENDRITIC CELLS; IN-VITRO; MOUSE MODELS; MURINE DENDRITIC CELLS; NOVEL STRATEGIES; SUPERPARAMAGNETICS; TUMOR TARGETING;

ANTIGENS; CELLS; DISEASES; IRON OXIDES; NANOPARTICLES; SUPERPARAMAGNETISM; TUMORS;

PEPTIDES;

ANTIGEN; DEXTRAN; FERUMOXTRAN-10; MAGNETITE NANOPARTICLE; NANOCAPSULE; PEPTIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DENDRITIC CELL; DRUG EFFECT; MOUSE; NEOPLASM;

ANIMALS; ANTIGENS; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; DEXTRANS; MAGNETITE NANOPARTICLES; MICE; NANOCAPSULES; NEOPLASMS; PEPTIDES;

EID: 84865117902     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2012.6379     Document Type: Article

References (41)

1. B. Pulendran and R. Ahmed, Cell 124, 849 (2006).
2. J. A. Berzofsky, M. Terabe, S. Oh, I. M. Belyakov, J. D. Ahlers, J. E. Janik, and J. C. Morris, J. Clin. Invest 113, 1515 (2004).
3. S. A. Rosenberg, J. C. Yang, and N. P. Restifo, Nat. Med. 10, 909 (2004).
4. A. W. Purcell, J. McCluskey, and J. Rossjohn, Nat. Rev. Drug Discov. 6, 404 (2007).
5. D. W. O'Neill, S. Adams, and N. Bhardwaj, Blood 104, 2235 (2004).
6. J. Banchereau and A. K. Palucka, Nat. Rev. Immunol. 5, 296 (2005).
7. R. M. Steinman, D. Hawiger, and M. C. Nussenzweig, Annu. Rev. Immunol. 21, 685 (2003).
8. S. T. Reddy, M. A. Swartz, and J. A. Hubbell, J. A. Trends Immunol. 27, 573 (2006).
9. P. J. Tacken, I. J. de Vries, R. Torensma, and C. G. Figdor, Nat. Rev. Immunol. 7, 790 (2007).
10. R. Langer, J. L. Cleland, and J. Hanes, Adv. Drug Deliv. Rev. 28, 97 (1997).
11. H. Shen, A. L. Ackerman, V. Cody, A. Giodini, E. R. Hinson, P. Cresswell, R. L. Edelson, W. M. Saltzman, and D. J. Hanlon, Immunology 117, 78 (2006).
12. M. Ferrari and G. Downing, BioDrugs 19, 203 (2005).
13. A. J. Almeida and E. Souto, Adv. Drug Deliv. Rev. 59, 478 (2007).
14. T. K. Jain, M. A. Morales, S. K. Sahoo, D. L. Leslie-Pelecky, and V. Labhasetwar, Mol. Pharm. 2, 194 (2005).
15. C. H. Lee, C. B. Chen, T. H. Chung, Y. S. Lin, and W. C. Lee, J. Nanosci. Nanotechnol. 10, 7965 (2010).
16. J. H. Lee, Y. M. Huh, Y. W. Jun, J. W. Seo, J. T. Jang, H. T. Song, S. Kim, E. J. Cho, H. G. Yoon, J. S. Suh, and J. Cheon, Nat. Med. 13, 95 (2007).
17. J. T. Jang, H. Nah, J. H. Lee, S. H. Moon, M. G. Kim, and J. Cheon, Angew. Chem. Int. Ed. 48, 1234 (2009).
18. P. A. Jarzyna, T. Skajaa, A. Gianella, D. P. Cormode, D. D. Samber, S. D. Dickson, W. Chen, A. W. Griffioen, Z. A. Fayad, and W. J. M. Mulder, Biomaterials 30, 6947 (2009).
19. J. H. Park, G. von Maltzahn, M. J. Xu, V. Fogal, V. R. Kotamraju, E. Ruoslahti, S. N. Bhatia, and M. J. Sailor, PNAS 107, 981 (2010).
20. H. P. Song, J. Y. Yang, S. L. Lo, Y. Wang, W. M. Fan, X. S. Tang, J. M. Xue, and S. Wang, Biomaterials 31, 769 (2010).
21. J. K. Vasir and V. Labhasetwar, Adv. Drug Deliv. Rev. 59, 718 (2007).
22. S. T. Reddy, A. Rehor, H. G. Schmoekel, J. A. Hubbell, and M. A. Swartz, J. Control Release 112, 26 (2006).
23. P. Elamanchili, M. Diwan, M. Cao, and J. Samuel, Vaccine 22, 2406 (2004).
24. T. Yoshikawa, N. Okada, A. Oda, K. Matsuo, K. Matsuo, H. Kayamuro, Y. Ishii, T. Yoshinaga, T. Akagi, M. Akashi, and S. Nakagawa, Vaccine 26, 1303 (2008).
25. S. Hamdy, O. Molavi, Z. Ma, A. Haddadi, A. Alshamsan, Z. Gobti, S. Elhasi, J. Samuel, and A. Lavasanifar, Vaccine 26, 5046 (2008).
26. Y. J. Kwon, S. M. Standley, S. L. Goh, and J. M. Frechet, J. Control Release 105, 199 (2005).
27. M. B. Lutz, N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler, J. Immunol Methods 223, 77 (1999).
28. S. T. Reddy, A. J. van der Vlies, E. Simeoni, V. Angeli, G. J. Randolph, C. P. O'Neil, L. K. Lee, and M. Swartz, J. A. Nat. Biotechnol. 25, 1159 (2007).
29. V. Manolova, A. Flace, M. Bauer, K. Schwarz, P. Saudan, and M. F. Bachmann, Eur. J. Immunol. 38, 1404 (2008).
30. D. K. Kim and J. Dobson, J. Mater. Chem. 19, 6294 (2009).
31. N. Brandhonneur, F. Chevanne, V. Vie, B. Frisch, R. Primault, M. F. Le Potier, and P. Le Corre, Eur. J. Pharm. Sci. 36, 474 (2009).
32. A. D. Gomes, C. N. Lunardi, F. H. Caetano, L. O. Lunardi, and A. E. D. Machado, Microscopy and Microanalysis 12, 399 (2006).
33. S. Singh, J. Nanosci. Nanotechnol. 10, 7906 (2010).
34. M. Diwan, M. Tafaghodi, and J. Samuel, J. Control Release 85, 247 (2002).
35. S. de Jong, G. Chikh, L. Sekirov, S. Raney, S. Semple, S. Klimuk, N. Yuan, M. Hope, P. Cullis, and Y. Tam, Cancer Immunol. Immunother 56, 1251 (2007).
36. M. W. Mortensen, L. Kahns, T. Hansen, P. G. Sorensen, O. Björkdahl, M. R. Jensen, H. J. Gundersen, and T. Bjoørnholm, J. Nanosci. Nanotechnol. 7, 4575 (2007).
37. E. Schlosser, M. Mueller, S. Fischer, S. Basta, D. H. Busch, B. Gander, and M. Groettrup, Vaccine 26, 1626 (2008).
38. C. S. Chong, M. Cao, W. W. Wong, K. P. Fischer, W. R. Addison, G. S. Kwon, D. L. Tyrrell, and J. Samuel, J. Control Release 102, 85 (2005).
39. J. M. Blander and R. Medzhitov, Nature 440, 808 (2006).
40. S. Jilek, M. Ulrich, H. P. Merkle, and E. Walter, Pharm Res. 21, 1240 (2004).
41. M. Yoshida and J. E. Babensee, J. Biomed. Mater. Res. A 71, 45 (2004).